SPECIAL REQUIREMENTS SECTION OF RFA-[number]
1. Plans to share research resources. All vectors for transgenic
production and mouse strains generated over the past several years
have been distributed freely to the broader academic community,
either before or immediately on publication. Indeed we have supplied
over 250 requesting laboratories with either vectors, mice, or
both. Requestees typically receive the desired reagents within
two weeks to two months of their request, depending on their chronological
position in the queue. The infrastructure for this rapid sharing
of newly developed reagents (both vectors and mice) continues to
be in place in my lab and supported by the Office of Technology
and Licensing, [Applicant Institution] (see attached letter by
[name]).
2. Intellectual property rights. Consistent with [Applicant Institution]'s
policy on intellectual property rights (see attached letter by
[name]), my lab will make available any and all strains of transgenic
mice produced under this grant for use at other academic or not-for-profit
institutions at no cost except for standard maintenance and transportation
expenses. [Applicant Institution] will reserve the right to use
these reagents for educational, research, or other nonbusiness
purposes. [Applicant Institution] may establish a non-exclusive
commercial license granting [Applicant Institution]'s rights
to use such animals at specific for-profit entities; in these cases,
[Applicant Institution] will maintain the right to grant non-exclusive
licenses for use of these materials by academic or not-for-profit
institutions.
Transfer of materials to not-for-profit entities will be implemented
under terms no more restrictive than the Uniform Biological Materials
Transfer Agreement (see example of the [Applicant Institution]
simple letter MTA attached in the appendix). Transfer of materials
to for-profit entities will be mediated through the [Applicant
Institution] Office of Technology and Licensing, and typically
involves a simple license agreement with execution or annual fees
as deemed appropriate, but in no way prohibitive to the ready distribution
of these reagents.
Intellectual property rights as pertains to [certain] reagents.
The Non-Profit Institute holds a patent on the use of [product]
in mammalian cells. They have made clear that any reagents harboring
[product] or [other product] sequences can be freely distributed
amongst academic, not-for-profit institutions. Such transfers would
be done under a joint [Applicant Institution]/ Non-Profit Institute
simple letter MTA (see attached letter from Dr. [Name], Office
of Technology and Licensing, [Applicant Institution]). Should reagents
be transferred to for-profit institutions, an inter-institutional
license ([Applicant Institution] / Non-Profit Institute) will be
drafted with execution or annual fees as deemed appropriate, but
in no way prohibitive to the ready distribution of these reagents.
Those reagents generated in collaboration with Dr. [Name] would
require a inter-institutional MTA involving [Applicant Institution]
/ Non-Profit Institute /Non-Profit Research Center. These simple
agreements are already in place.
Intellectual property rights as pertains to [certain] reagents.
For-Profit Company holds a patent on the use of [product] in [location].
The memorandum of understanding between For-Profit Company and
PHS makes it clear that any and all [products] containing reagents
generated under this grant can be readily shared with the broader
academic community under a simple MTA, and do not infringe on the
uses under restriction (namely: [this], [that] and [a third]) Should
our reagents be transferred to for-profit institutions, an inter-institutional
license ([Applicant Institution]/ For-Profit Company) will be drafted
with execution or annual fees as deemed appropriate. Of course,
current For-Profit Company licensing issues as surrounds for-profit
institutions would have to be settled between that institution
and For-Profit Company.
Intellectual property rights as pertains to the [certain] locus.
The Non-Profit Research Center holds a license on use of [certain]
sequences. This license stipulates free use for academic, not-for-profit
institutions and involves a simple letter MTA. Those reagents generated
in collaboration with Dr. [Name] that incorporate [certain] sequences
will require an inter-institutional MTA involving [Applicant Institution]
Medical School and Non-Profit Research Center. These simple agreements
are currently in place. Should reagents be transferred to for-profit
institutions, an inter-institutional license ([Applicant Institution]
Medical School/Non-Profit Research Center) will be drafted with
execution or annual fees as deemed appropriate, but in no way prohibitive
to the ready distribution of these reagents.
|